Live feed
Filing
SC 13G/A
SC 13G/A0001193125-19-040177·Actinium Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
Actinium Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 00507W107
Event date: 2018-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 2.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-19-040177
- Form type
- SC 13G/A
- Filer
- Actinium Pharmaceuticals, Inc.
- CIK
- CIK 1388320
- Filed
- Feb 14, 2019
- Reporting period
- Dec 31, 2018
- Description
- Schedule 13G beneficial ownership